Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
107.56
(
-0.64%
)
Bitcoin
67,463.21
(
2.28%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: urche post# 4723

Wednesday, 11/10/2004 12:54:13 PM

Wednesday, November 10, 2004 12:54:13 PM

Post# of 257302
>> This adds validity to the claim that CTL-4 blockade is an effective immunomodulatory strategy. <<

When some companies are developing drugs which up-regulate CTLA-4 (MEDX) and other companies are developing drugs which down-regulate CTLA-4 (BMY), it’s a good sign that CTLA-4 is a promising target for pharmaceutical intervention.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today